RT @wjurol: Despite the promise of liquid biopsy-derived miRNAs as cancer biomarkers, their validation and clinical implementation remains…
RT @wjurol: Despite the promise of liquid biopsy-derived miRNAs as cancer biomarkers, their validation and clinical implementation remains…
RT @wjurol: Despite the promise of liquid biopsy-derived miRNAs as cancer biomarkers, their validation and clinical implementation remains…
RT @wjurol: Despite the promise of liquid biopsy-derived miRNAs as cancer biomarkers, their validation and clinical implementation remains…
Although #ProstateCancer patients with oligometastatic disease had a more favorable prognosis, no serum-derived biomarkers allowing for prospective discrimination of oligo- and polymetastatic PC patients could be identified. https://t.co/8Jjl20ENpo @wjurol
Despite the promise of liquid biopsy-derived miRNAs as cancer biomarkers, their validation and clinical implementation remains difficult. https://t.co/o37xbaNatQ https://t.co/hVSHyDLmuG
RT @EliseDeBleser: Discriminating between oligo- and polymetastatic PC in selecting the right patients for MDT remains challenging. However…
RT @_ShankarSiva: Scientific honesty - miRNA signatures did not predict for oligo versus polymetastatic #prostatecancer - https://t.co/PAIm…
RT @DhondtBert: MiRNA's zijn beloftevolle merkers voor kanker, maar hen van het laboratorium naar de kliniek brengen blijft moeilijk. Techn…
Also takes collective effort from journals to publish "negative" findings (I don't like this term - so much "negativity" in it!).
RT @_ShankarSiva: Scientific honesty - miRNA signatures did not predict for oligo versus polymetastatic #prostatecancer - https://t.co/PAIm…
RT @radiolobt: Discovery and validation of a serum microRNA signature to characterize oligo- and polymetastatic prostate cancer: not ready…
RT @_ShankarSiva: Scientific honesty - miRNA signatures did not predict for oligo versus polymetastatic #prostatecancer - https://t.co/PAIm…
RT @_ShankarSiva: Scientific honesty - miRNA signatures did not predict for oligo versus polymetastatic #prostatecancer - https://t.co/PAIm…
RT @_ShankarSiva: Scientific honesty - miRNA signatures did not predict for oligo versus polymetastatic #prostatecancer - https://t.co/PAIm…
RT @_ShankarSiva: Scientific honesty - miRNA signatures did not predict for oligo versus polymetastatic #prostatecancer - https://t.co/PAIm…
RT @_ShankarSiva: Scientific honesty - miRNA signatures did not predict for oligo versus polymetastatic #prostatecancer - https://t.co/PAIm…
RT @_ShankarSiva: Scientific honesty - miRNA signatures did not predict for oligo versus polymetastatic #prostatecancer - https://t.co/PAIm…
RT @_ShankarSiva: Scientific honesty - miRNA signatures did not predict for oligo versus polymetastatic #prostatecancer - https://t.co/PAIm…
RT @PercyLeeMD: That is good science. I think serious scientists would love to share negative data. It’s worth sharing for the greater good…
RT @_ShankarSiva: Scientific honesty - miRNA signatures did not predict for oligo versus polymetastatic #prostatecancer - https://t.co/PAIm…
RT @_ShankarSiva: Scientific honesty - miRNA signatures did not predict for oligo versus polymetastatic #prostatecancer - https://t.co/PAIm…
RT @_ShankarSiva: Scientific honesty - miRNA signatures did not predict for oligo versus polymetastatic #prostatecancer - https://t.co/PAIm…
RT @_ShankarSiva: Scientific honesty - miRNA signatures did not predict for oligo versus polymetastatic #prostatecancer - https://t.co/PAIm…
RT @_ShankarSiva: Scientific honesty - miRNA signatures did not predict for oligo versus polymetastatic #prostatecancer - https://t.co/PAIm…
RT @_ShankarSiva: Scientific honesty - miRNA signatures did not predict for oligo versus polymetastatic #prostatecancer - https://t.co/PAIm…
RT @PercyLeeMD: That is good science. I think serious scientists would love to share negative data. It’s worth sharing for the greater good…
RT @_ShankarSiva: Scientific honesty - miRNA signatures did not predict for oligo versus polymetastatic #prostatecancer - https://t.co/PAIm…
RT @_ShankarSiva: Scientific honesty - miRNA signatures did not predict for oligo versus polymetastatic #prostatecancer - https://t.co/PAIm…
RT @_ShankarSiva: Scientific honesty - miRNA signatures did not predict for oligo versus polymetastatic #prostatecancer - https://t.co/PAIm…
RT @PercyLeeMD: That is good science. I think serious scientists would love to share negative data. It’s worth sharing for the greater good…
Extremely important to be fair and objective. Seek for truth, not for other things. #UroSoMe
Agree, however....Plenty of us are happy, willing and prepared to publish negative data....but publication bias is real and a barrier to dissemination of negative studies. So kudos to the authors AND journal in this case.
RT @PercyLeeMD: That is good science. I think serious scientists would love to share negative data. It’s worth sharing for the greater good…
That is good science. I think serious scientists would love to share negative data. It’s worth sharing for the greater good.I wish good journals would take negative data as seriously as positive data. #radonc @subatomicdoc @ElsevierConnect @SBRT_CR @RTen
Scientific honesty - miRNA signatures did not predict for oligo versus polymetastatic #prostatecancer - https://t.co/PAImz5Gr2E. When something doesn't work, it takes courage to let the world know about it. Thx -@EliseDeBleser @piet_ost et al. #Precisionme
Discovery and validation of a serum microRNA signature to characterize oligo- and polymetastatic prostate cancer: not ready for prime time. https://t.co/I2bK8feu4n
MiRNA's zijn beloftevolle merkers voor kanker, maar hen van het laboratorium naar de kliniek brengen blijft moeilijk. Technische en biologische oorzaken van miRNA variatie dienen daarom verder in kaart gebracht te worden https://t.co/qPawVkpGq2 #wecomm @We
RT @DhondtBert: Despite the promise of liquid biopsy-derived miRNAs as cancer biomarkers, their validation and clinical implementation rema…
RT @piet_ost: Discovery and validation of a serum microRNA signature to characterize oligo- and polymetastatic prostate cancer: not ready f…
RT @piet_ost: Discovery and validation of a serum microRNA signature to characterize oligo- and polymetastatic prostate cancer: not ready f…
RT @EliseDeBleser: Discriminating between oligo- and polymetastatic PC in selecting the right patients for MDT remains challenging. However…
RT @piet_ost: Discovery and validation of a serum microRNA signature to characterize oligo- and polymetastatic prostate cancer: not ready f…
RT @DhondtBert: Despite the promise of liquid biopsy-derived miRNAs as cancer biomarkers, their validation and clinical implementation rema…
RT @EliseDeBleser: Discriminating between oligo- and polymetastatic PC in selecting the right patients for MDT remains challenging. However…
Discriminating between oligo- and polymetastatic PC in selecting the right patients for MDT remains challenging. However, we are convinced that further efforts into this field can lead to great results! @DhondtBert @piet_ost @crighent @LumenNicolaas @Aurel
RT @piet_ost: Discovery and validation of a serum microRNA signature to characterize oligo- and polymetastatic prostate cancer: not ready f…
RT @DhondtBert: Despite the promise of liquid biopsy-derived miRNAs as cancer biomarkers, their validation and clinical implementation rema…
Discovery and validation of a serum microRNA signature to characterize oligo- and polymetastatic prostate cancer: not ready for prime time. @DhondtBert @_ShankarSiva @jvdesomp @crighent https://t.co/PDuM8VI1ix
Despite the promise of liquid biopsy-derived miRNAs as cancer biomarkers, their validation and clinical implementation remains difficult. Nonetheless, encouraging results to keep working towards a solution! https://t.co/mFrkfA7i92